CardioScan
PrivateLast Round
Private Equity
Oct 7, 2020
Est. Valuation
$42.16M
Total Funding Raised
$6.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CardioScan operates in Healthcare & Life Sciences and is based in Camberwell, Victoria. Its latest recorded funding round was a Private Equity round in October 2020.
CardioScan is a healthcare IT company that provides cardiac monitoring equipment and reporting services to pathology laboratories and hospital networks.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, EHR & EMR, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioScan Comparables
Compare CardioScan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| The ScottCare Corporation | 81% | |
| Biotricity Inc | 76% | |
| Philips | 76% |
For institutional investors. Book with your work email.
CardioScan Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
CardioScan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 360 Capital Group | Private Equity |
| Harbert Management Corporation | Buyout/LBO |
| Alvia Asset Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Now operating across eleven countries.
- Apr 1, 2026
Certified as a Great Place to Work®.
For institutional investors. Book with your work email.
CardioScan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CardioScan's valuation, stock price, and market status.
Is CardioScan a public or private company?
CardioScan is a private company.
What is the current stock price of CardioScan?
CardioScan is a private company, so its shares have no public market price. Caplight tracks CardioScan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CardioScan worth (valuation)?
CardioScan's valuation is estimated at $42.2M based on funding round data.
Can I buy CardioScan stock?
CardioScan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CardioScan's last funding round?
CardioScan's most recent funding round was Private Equity on October 7, 2020.
Who are the main investors in CardioScan?
Key investors in CardioScan include 360 Capital Group, Harbert Management Corporation.
Will CardioScan IPO soon?
No public IPO plans have been announced for CardioScan.
How can I track CardioScan secondary market activity?
Caplight tracks bids, offers, and trades in CardioScan's shares on secondary markets.